AHPBA Registry Database (Collection of Clinical Data Related to Pancreatic Cancer & Treatment - Irreversible Electroporation (IRE))

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Primary Objective(s) To collect clinical data related to the treatment outcomes of Pancreatic IRE in order to develop an evidence base such that physicians can provide the best possible care to patients with pancreatic cancer requiring surgical intervention. Secondary Objective(s) To collect data on adverse events and complications related to IRE treatment. The AHPBA (Americas Hepato-Pancreato-Biliary Association) will be responsible for data collection and will periodically audit the data for quality assurance purposes. The AHPBA will review outcomes reported by each participating Research Institution and if outcomes are in the lower percentile, the investigators will be offered support to analyze the reasons for the suboptimal outcomes and may seek support to improve outcomes. The participating Research Institutions will receive a certificate annually that acknowledges their participation in the Research Project.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• more than 18 years of age

• Diagnosed with pancreatic cancer and has consented to undergo the NanoKnife procedure per the treating physician

• Willing and able to comply with the protocol requirements

• Able to comprehend and sign the Informed Consent Form in English or Spanish

Locations
United States
Texas
Liver Institute of Methodist Dallas Medical Center
RECRUITING
Dallas
Contact Information
Primary
Crystee Cooper, DHEd
clinicalresearch@mhd.com
214-947-1280
Backup
Zaid Haddadin, MS
clinicalresearch@mhd.com
214-947-4459
Time Frame
Start Date: 2017-12-20
Estimated Completion Date: 2024-12
Participants
Target number of participants: 30
Related Therapeutic Areas
Sponsors
Leads: Methodist Health System

This content was sourced from clinicaltrials.gov